Type 5 diabetes, a newly recognised form of the disease, affects lean and malnourished teens and young adults in low- and middle-income countries. Officially classified by the International Diabetes ...

Thailand: In a landmark move at the World Diabetes Congress 2025 in Bangkok, the International Diabetes Federation (IDF) ...

In diabetes care, AI has propelled the field forward through predictive modeling, decision support, and real-time glycemic ...

This summary of health news briefs includes reports on how the U.S.-China trade war impacts drug costs, EU approval of ...

A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...

Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a ma ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing ...

Cardiovascular risk factors, accelerated by depression and anxiety, increase a patient’s risk for end-stage renal disease, according to a study presented at the American College of Cardiology’s 2025 ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, and Okava Pharmaceuticals, Inc.

In 1989, Ronald Johnson did not think he would live to see old age. Johnson, a Black gay man, was diagnosed with HIV that ...